Markers of Prostate Cancer Aggressiveness
Early and accurate detection of deadly diseases is highly desired, but selecting the best biomarker is challenging. Metabolon’s technology is uniquely positioned to identify biomarkers, accelerate MOA, further personalized medicine and tailor therapy approaches.
Prostate cancer is the third most fatal cancer in men. While tests exist, current screenings for prostate-specific antigen (PSA) levels show weak correlation for prostate cancer malignancy. This weak association makes diagnosis of invasive prostate cancer very difficult.